EP2174587B1 - Dispositif d'implantation pour capteurs de métabolites - Google Patents

Dispositif d'implantation pour capteurs de métabolites Download PDF

Info

Publication number
EP2174587B1
EP2174587B1 EP08165704A EP08165704A EP2174587B1 EP 2174587 B1 EP2174587 B1 EP 2174587B1 EP 08165704 A EP08165704 A EP 08165704A EP 08165704 A EP08165704 A EP 08165704A EP 2174587 B1 EP2174587 B1 EP 2174587B1
Authority
EP
European Patent Office
Prior art keywords
implantation
cannula
hydraulic
implantation device
sensor element
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP08165704A
Other languages
German (de)
English (en)
Other versions
EP2174587A1 (fr
Inventor
Achim Müller
Peter Herbrechtsmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eyesense AG
Original Assignee
Eyesense AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyesense AG filed Critical Eyesense AG
Priority to DE502008003439T priority Critical patent/DE502008003439D1/de
Priority to EP08165704A priority patent/EP2174587B1/fr
Priority to AT08165704T priority patent/ATE507768T1/de
Priority to ES08165704T priority patent/ES2364375T3/es
Priority to TW98132727A priority patent/TWI471116B/zh
Priority to CN200980144403.0A priority patent/CN102209489B/zh
Priority to US13/122,110 priority patent/US8652101B2/en
Priority to CA2739236A priority patent/CA2739236C/fr
Priority to PCT/EP2009/062824 priority patent/WO2010037848A1/fr
Publication of EP2174587A1 publication Critical patent/EP2174587A1/fr
Application granted granted Critical
Publication of EP2174587B1 publication Critical patent/EP2174587B1/fr
Priority to HK12102304.3A priority patent/HK1161965A1/xx
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • A61B2017/00539—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated hydraulically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • A61B17/3421—Cannulas
    • A61B2017/3445—Cannulas used as instrument channel for multiple instruments
    • A61B2017/3447—Linked multiple cannulas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Definitions

  • the invention relates to an implantation device for implanting a sensor element for detecting at least one analyte.
  • sensor elements are used in particular for the determination of at least one metabolite concentration in a body fluid and / or a body tissue.
  • metabolites may include, but are not limited to, blood glucose, lactate, cholesterol, or other types of analytes or metabolites.
  • the sensor element can in principle also be used in other areas of analysis, for example in the field of chemical analysis, in particular in-situ analysis, process monitoring or in similar areas.
  • the invasive technologies for determining the analyte concentration are usually based on sensors that can be implanted in a body tissue and / or a body fluid and that determine the analyte concentration in an optical and / or electrochemical manner can.
  • optical systems use at least one sensor material which changes at least one optically measurable property in the presence of one or more specific analytes.
  • This optically measurable property may be configured in a variety of ways, many of which are known in the art, sensor materials, and measuring devices. All of these known sensor materials can in principle also be used in the context of the present invention. However, sensor elements based on electrochemical measuring methods can also be used in the context of the present invention with the implantation device.
  • the ocular sensor comprises as sensor material a glucose receptor labeled with a first fluorescent label and a glucose competitor labeled with a second fluorescent label ("donor").
  • the two fluorescent labels are chosen such that when the competitor is bound to the receptor, the fluorescence of the second fluorescent label is quenched due to resonant fluorescence energy transfer.
  • the proportion of the fluorescently labeled competitor that has been displaced by the glucose can be measured. In this way, the glucose concentration in the eye fluid can be determined. The measurement can in turn be used to deduce the blood glucose concentration.
  • Other types of detection are also conceivable and familiar to the person skilled in the art, for example a fluorescence detection of the first fluorescent label.
  • WO 02/087429 describes a fluorescence photometer by means of which blood glucose concentrations can be determined by measuring the glucose concentrations in the ocular fluid.
  • the illustrated device is capable of simultaneously measuring two fluorescence intensities at different wavelengths.
  • a sensor element for determining a glucose concentration using an optical waveguide At the distal end of the optical waveguide, a sensor element is applied to it which comprises a binding protein capable of binding with at least one target analyte.
  • the sensor element further comprises at least one reporter group which undergoes a luminescence change as the analyte concentrations change.
  • the sensor element comprises reference groups having luminescent properties that do not substantially change as the analyte concentrations change.
  • US 7,226,414 B2 describes a glucose sensor device for implantation within the subcutaneous tissue of an animal body.
  • a sensor material is disposed in a first chamber, wherein glucose may enter the first chamber from the body tissue.
  • the sensor element further comprises a reference chamber with a reference solution.
  • optical waveguide fibers is again proposed, which connect a detection device with the chambers.
  • a challenge with implantable sensor elements is in particular a uniform, reproducible and nevertheless painless implantation of the sensor elements into the body tissue.
  • the implantation depth and the sensor position have a significant effect on the signal quality. It is also desirable, in order to ensure the most painless implantation possible and then as painless as possible removal of the sensor elements, a minimally invasive implantation technology.
  • WO94 / 04217 a device for the simultaneous injection of a liquid and a transponder into an animal tissue is described. This device allows for a single puncture to inject both components.
  • the implantation device should enable a reproducible implantation of sensor elements, as well as ensuring painless embedding of the sensor elements in the body tissue.
  • the implantation device can in principle be used to implant sensor elements for detecting at least one analyte in a body fluid and a body tissue in the body tissue.
  • the sensor elements may comprise one or more of the sensor elements described above.
  • the sensor elements can be used in particular for determining at least one metabolite concentration in a body fluid.
  • detection can be understood to mean a quantitative and / or qualitative determination of an analyte concentration, that is to say a determination of the amount and / or concentration of the analyte in the body fluid and / or the answer to the question as to whether the analyte is actually present in the body fluid is included.
  • the implantation device comprises at least one cannula for penetrating a skin surface of a patient.
  • a cannula is to be understood as meaning a substantially tubular structure which may be rigid or flexible and which has an inner lumen.
  • This inner lumen can comprise a constant or a variable cross-section.
  • the cannula may comprise a plurality of annularly arranged lumens, in which, for example, different components of the sensor elements can be accommodated. Adjacent arrangements of several lumens are also conceivable.
  • a cut can be made in the skin surface before using the implantation device.
  • the cannula itself has an element for penetrating the skin surface, for example a cannula tip and / or a sharp-edged element arranged to perforate the skin surface.
  • the cannula should have at least one receiving area for receiving the sensor element.
  • this receiving area may comprise a region between a cannula tip which is first inserted into the skin surface and a constriction within the cannula, for example a constriction within the inner lumen of the cannula.
  • the receiving area does not differ from the remaining inner lumen of the cannula.
  • the receiving region can in particular be designed in the form of a circular cylinder in order to accommodate circular cylindrical sensor elements, that is to say sensor elements with a circular cross section and an elongate shape.
  • the receiving area may have a diameter of between 100 ⁇ m and 1 mm, wherein particularly preferred diameters are in the range of 200 to 500 ⁇ m.
  • lengths of between 1 mm and 8 mm, preferably between 2 mm and 5 mm, are suitable for the length of the receiving region and thus the length of the sensor elements.
  • the implantation device has at least one hydraulic container connected to the cannula for receiving a hydraulic fluid.
  • the connection between the hydraulic container and the cannula can be rigid, for example, so that the hydraulic container and the cannula together form an implantation unit.
  • the cannula may be directly connected to the hydraulic container, but as an alternative connections via intermediate elements are possible, for example one or more tubes.
  • the hydraulic tank should be designed to be resistant to pressure in particular.
  • gases and / or liquids are suitable as the hydraulic fluid, with liquids being preferred.
  • the hydraulic fluid should preferably be made biocompatible. Therefore, the use of a saline solution, in particular a physiological saline solution, as the hydraulic fluid is particularly preferred.
  • other types of fluids may be used, as well as mixtures or combinations of different fluids.
  • the implantation device furthermore has at least one pressure generating device.
  • This pressure generating device should be adapted to the hydraulic fluid with a pressure, that is, an overpressure and / or a negative pressure to apply. In this way, by applying a positive pressure to the hydraulic fluid in the hydraulic reservoir and thus in the cannula, the sensor element can be transferred from the cannula into the body tissue by means of this pressurized hydraulic fluid, for example hydraulically pushed into the body tissue.
  • the pressure generating device for generating the overpressure or underpressure in the hydraulic container may in particular comprise at least one pressure piston which is hydraulically connected to the hydraulic reservoir.
  • the Druckkolbcn be wholly or partially included in the hydraulic tank.
  • the pressure piston can also be accommodated in another element of the implantation device, for example in a separate pressure generator, which is hydraulically connected to the hydraulic reservoir, for example via a hose or pipe connection.
  • a separate pressure generator which is hydraulically connected to the hydraulic reservoir, for example via a hose or pipe connection.
  • other types of pressure generators are conceivable in principle, for example, pressure generator with a separate pressure source, such as a pump, an external pressure source or the like.
  • the implantation unit which comprises the cannula and the hydraulic container, is movable relative to the pressure piston as a whole.
  • the implantation unit may be movable axially, that is to say along an axis of the implantation device, relative to the pressure piston.
  • the pressure piston can be fixed in its position, for example in its position relative to the main surface of the patient, so that only the implantation unit is moved relative to the pressure piston and thus also relative to the skin surface.
  • the pressure piston can be connected, for example, with at least one support surface for resting on the skin surface, for example via a piston rod. This support surface may be identical in part or in part to a device which is also connected for setting and / or limitation of the implantation depth.
  • Such a device for adjusting and / or limiting the implantation depth which may also be provided independently of the configuration of the pressure generator or pressure piston, can significantly improve the reproducibility of the implantation of the sensor element.
  • this reproducibility is of crucial importance for signal quality, especially in optical sensor elements.
  • such a device for adjusting and / or limiting the implantation depth may comprise a depth stop, for example a stopper, which limits a movement of the implantation unit relative to the skin surface and thus a penetration depth of the cannula into the skin surface.
  • the device may comprise a support surface for resting on the skin surface, which may thus provide a fixed position relative to the skin surface.
  • this bearing surface can be a broad contact surface, that is to say a bearing surface with a size of a few tens of square millimeters up to a few square centimeters.
  • the support surface may, for example, partially surround the cannula or the cannula tip in an annular manner (for example annularly).
  • the support surface may in particular be connected to the pressure piston, for example via a piston rod.
  • the implantation unit which comprises the hydraulic container and the cannula, is connected to this device via at least one spring element.
  • This spring element which may be configured, for example, as a spiral spring element or as a leaf spring element, which may alternatively or additionally comprise other types of elastic elements, may serve as a return spring and, after implantation, favoring withdrawal of the cannula from the body tissue.
  • the spring element can in turn be connected to the support surface and act on the implantation unit with a bias relative to this support surface or push away from this support surface.
  • the hydraulic reservoir of the implantation device is connected via at least one connection to a hydraulic reservoir for receiving and providing the hydraulic fluid.
  • this hydraulic reservoir may include a storage tank.
  • the connection may include, for example, one or more hose connections that tolerate movement of the implantation unit relative to the hydraulic supply.
  • the hydraulic supply can also be wholly or partially firmly connected to the implantation unit, for example with the hydraulic supply.
  • the connection comprises at least one valve. It is particularly preferred if this valve comprises a check valve.
  • the valve can be configured to open at a negative pressure in the hydraulic tank and to allow a backflow of hydraulic fluid into the hydraulic tank.
  • the latter embodiment of the implantation device allows a particularly simple and reproducible implantation of the sensor elements.
  • the implantation unit can be lowered with the hydraulic container and the cannula relative to the skin surface, so that the cannula tip penetrates into the receiving area with the skin surface.
  • the pressure generating device may be configured such that a negative pressure is generated in the hydraulic tank during this lowering. This can be done, for example, that, as described above, a fixed pressure piston is used. If the implantation unit is lowered relative to this pressure piston, a negative pressure is created in the hydraulic container. Hydraulic fluid can then flow into the hydraulic reservoir via the valve, in particular the check valve.
  • the pressure in the hydraulic container rises due to the fixed position of the pressure piston.
  • This embodiment of the implantation offers the advantage that the implantation can be limited to handling the implantation unit and controlling the position of this implantation unit.
  • a separate control of the pushing out of the sensor element from the receiving area of the cannula into the tissue is not necessary since this pushing out or transferring into the body tissue takes place automatically by means of the hydraulic fluid.
  • the implantation movement is generally coupled to the pressure generator in such a way that an implantation movement automatically effects the transfer of the sensor element from the cannula into the body tissue.
  • the implantation device can also be set up for removal of the sensor element from the body tissue.
  • a cannula corresponding to the sensor element can be introduced through the skin surface into the body tissue, so that the sensor element is fully or partially inserted into the opening of the cannula.
  • the pressure generating device may be configured to generate a negative pressure in the hydraulic fluid, whereby the sensor element may be sucked into the cannula.
  • this Purpose to close the valve connecting the hydraulic supply and the hydraulic reservoir, or use a reversed check valve.
  • a negative pressure in the hydraulic fluid can be generated, by means of which the sensor element is completely sucked into the cannula.
  • Another embodiment of the pressure control is possible, for example, a pressure control, in which the negative pressure takes place only during the subsequent renewed lifting and thus removing the cannula from the body tissue.
  • Various embodiments are conceivable.
  • the cannula can have at least one constriction, as described above.
  • This constriction which can be configured for example in the form of a constriction of the inner lumen of the cannula and / or in the form of a conical constriction of the inner lumen of the cannula, prevents further penetration of the sensor element in the direction of the hydraulic container.
  • the implantation device is set up such that the sensor element can be produced completely or partially directly in the implantation device.
  • sensor elements can comprise crosslinkable materials which can be crosslinked directly in the cannula.
  • crosslinkable plastics in particular crosslinkable hydrogels, which can be crosslinked for example by a photochemical excitation.
  • the cannula is at least partially transparent to electromagnetic radiation, in particular to light. In particular, there should be transparency for light in the ultraviolet spectral range.
  • the implantation device may comprise at least one light source for crosslinking the at least one crosslinkable material of the sensor element in the cannula, for example a light source for generating ultraviolet radiation.
  • the proposed implantation device in one or more of the embodiments described above thus enables a reliable and highly reproducible implantation of sensor elements of various types.
  • the implantation can be painless and with exactly predefinable implantation depth in different types of body tissue take place, for example, the implantation depth by changing a setting (for example by means of a screw and / or an electromechanical device) of the implantation device can be realized.
  • the implantation device or the implantation unit can be manually movable.
  • an automatic positioning or an automatic drive of the implantation unit may also be provided, for example a drive by means of one or more actuators which bring about a propulsion and / or return of the implantation unit, in particular the cannula, into or out of the body tissue .
  • the implantation can be done on the one hand in opaque body tissue, for example in skin areas, or can also be done in transparent tissue areas, such as a tissue area on the eye.
  • a corresponding bearing surface which can be optimally adapted to the physical conditions in the region of the implantation site, a high reproducibility can be ensured in this case.
  • the invention is not limited to the embodiments.
  • the embodiments are shown schematically in the figures.
  • the same reference numerals in the individual figures designate the same or functionally identical or with respect to their functions corresponding elements.
  • FIGS. 1A to 1C an implantation device 110 according to the invention is shown in a schematic representation from the side. At the same time serve the FIGS. 1A to 1C , which show different stages of an implantation process of a sensor element 114 through a skin surface 112 into a tissue 116, to illustrate a possible embodiment of an implantation process by means of the implantation device 110.
  • the implantation device 110 comprises a cannula 118 with an implantation tip 120 at its end facing the tissue 116.
  • This implantation tip 120 is configured in the figures as a blunt implantation tip 120.
  • this implantation tip 120 can also be designed with a sharp-edged or pointed element, for example by, as is usual with many cannulas, the implantation tip 120 being chamfered and thus formed with sharp edges. In this way, a separate instrument for creating an opening in the skin surface 112 is not required, but the implantation tip 120 may itself provide the opening in the skin surface 112 required for its penetration into the tissue 116.
  • the cannula 118 is shown in the simple embodiment shown in the figures as a cylindrical cannula 118, with a cylindrical inner lumen 122. However, other embodiments are possible.
  • a receiving region 124 is provided at the end of the inner lumen 122 facing the implantation tip 120.
  • This receiving area 124 serves to receive the sensor element 114 and is limited at its upper end remote from the implantation tip 120 by a narrowing 126 in the cannula 118.
  • the constriction 126 is formed in the illustrated embodiment as an inward bead, so as an inwardly projecting thickening of the wall of the cannula 118.
  • other configurations are possible in principle.
  • the implantation tip 120 facing away from the cannula 118 is connected to a hydraulic tank 128. It is in the FIGS. 1A to 1C a fixed connection between cannula 118 and hydraulic container 128 is provided so that the hydraulic container 128 and the cannula 118 together form an implantation unit 130, which in the illustrated embodiment is designed as a rigid implantation unit.
  • the connection between the hydraulic tank 128 and the cannula 118 is configured funnel-shaped in the illustrated embodiment, so that in the hydraulic tank 128 recorded hydraulic fluid 132, for example, physiological saline, from the hydraulic tank 128 can easily flow into the cannula 118.
  • the hydraulic tank 128 is connected via a connection 136 with a merely in Figure 1A and only schematically shown hydraulic supply 138 connected.
  • the connection 136 comprises in the illustrated embodiment, a valve 140, for example, a inwardly, inside the hydraulic container 128 opening valve, such as a check valve.
  • a valve 140 for example, a inwardly, inside the hydraulic container 128 opening valve, such as a check valve.
  • the implantation device 110 comprises a pressure generating device 142 for generating an overpressure and / or underpressure within the hydraulic tank 128.
  • This pressure generating device 142 comprises in the illustrated embodiment a pressure piston 144, which is connected to a piston rod 146.
  • This piston rod 146 in turn is connected to a support 148 with a support surface 150 for resting on the skin surface 112.
  • This pad 148 has an opening 152 which annularly surrounds the cannula 118 and through which the cannula 118 can be lowered into the tissue 116.
  • the implantation unit 130 is therefore movable as a whole relative to the pressure piston, the piston rod 146 and the support 148 axially, that is, along the axis 134.
  • the implantation device 110 in the embodiment shown in the figures further comprises a device 154 for limiting and / or adjusting the implantation depth.
  • the device 154 comprises the support 148 with the support surface 150 and the opening 152.
  • the device 154 includes a depth stop 156 which, for example, protrudes vertically from the support 148 and acts as a stopper.
  • the depth stop 156 is such as in FIG FIG. 1B recognizable, designed to abut on a hydraulic container 128 in the funnel-shaped transition region to the cannula 118 received ring member 158 and thereby limit the penetration depth of the cannula 118 into the tissue 116.
  • the device 154 or the implantation device 110 comprises a spring element 160.
  • This spring element 160 which may be configured, for example, as a helical spring, serves as a return spring and is at one end on the support 148 and at another end to the hydraulic tank 128 or the ring element 158th supported. In this way, the spring element 160 is compressed upon penetration of the cannula 118 into the tissue 116, so that penetration of the cannula 118 against the spring force of this spring element 160 must take place.
  • the upward movement on the other hand, in which the cannula 118 is pulled out of the tissue 116 again, is preferably assisted by the spring force of the spring element 160.
  • the implantation unit 130 is located above the skin surface 112.
  • the sensor element 114 is accommodated in the receiving region 124.
  • the sensor element 114 can also be generated in whole or in part only.
  • the cannula 118 can be configured as a transparent cannula at least in the region of the receiving region 124.
  • transparent plastics, transparent ceramics or glass can be used as cannula material in this case. Also composite materials are possible.
  • the implantation device 110 may include, for example, a light source, not shown in the figures, which illuminates the receiving area 124 from the outside, so that a polymerization of the sensor element 114 in the receiving area 124 can take place.
  • a ready-made sensor element 114 can also be loaded into the receiving region 124, in order then to place the implantation device 110 in the in Figure 1A illustrated initial state in which the support 148 rests on the Hautoberflambac 112 to bring.
  • the implantation unit 130 as in FIG. 1B shown lowered relative to the support 148.
  • This lowering can for example be done manually or driven by one or more actuators.
  • the actuator is not shown in the figures and may for example be connected between the support 148 and the implantation unit 130 in order to drive a relative movement of these elements 130, 148.
  • the design using at least one actuator offers the advantage that the speed of penetration into the tissue 116 can be designed to be particularly uniform, whereby a uniformity of the implantation and the most painless implantation can be ensured.
  • an opening in the Skin surface 112 may be generated, or the cannula 118 may itself be configured with a pointed end.
  • the lowering of the implantation unit 130 according to FIG. 1B takes place until the ring member 158 abuts against the depth stop 156.
  • the depth stop 156 may, for example, also be designed as an adjustable depth stop, so that the penetration depth and thus the implantation depth can be influenced in a targeted manner. Alternatively or additionally, for example, the position of the ring element 158 can be changed to make an adjustment of the implantation depth. Other options are conceivable.
  • the plunger 144 preferably remains in a fixed position relative to the skin surface 112 by means of the piston rod 146, so that de facto this plunger 144 rises within the hydraulic container 128 and the volume of hydraulic fluid 132 within the hydraulic container 128 increases. Due to this negative pressure, the check valve 140 opens, and hydraulic fluid 132 from the hydraulic reservoir 138 can flow into the interior of the hydraulic tank 128.
  • FIG. 2 an embodiment of a sensor arrangement 162 is shown, which one by means of the implantation device 110, for example according to the embodiment in the FIGS. 1A to 1C , implantable sensor element 114 and a detection device 164.
  • a plurality of sensor elements 114 can be implanted by means of the implantation device 110, wherein FIG. 2 only a specific embodiment is shown in the implanted state.
  • the sensor element 114 has a one-piece molded body 166 with a sensor end 168 and a coupling end 170.
  • the molded body 116 is formed in this embodiment, for example, as a continuous hydrogel molded body.
  • the molded body 166 has a substantially cylindrical shape, with a diameter D of about 200 to 500 microns and a total length L of about 2 to 5 mm.
  • the sensor element 114 is subdivided into a sensor region 172, which points into the interior of the tissue 116 in the implanted state, and a transparent coupling part 174.
  • the sensor region 172 has a length l 1 of approximately 200 to 500 ⁇ m.
  • a sensor material 176 is embedded in a matrix material 178, wherein the matrix material 178 may also be present, for example, in the region of the coupling part 170.
  • the matrix material 178 may comprise, for example, a transparent hydrogel.
  • the sensor element 114 may optionally be surrounded by a coating 180, for example a biocompatible coating and / or a coating with a healing-promoting agent.
  • the coating 180 can be applied to the molded body 166, for example, in a layer-by-layer process and / or a plasma coating process.
  • the transparent coupling part 174 serves as a "window" for the extraction of an optical signal 182.
  • This optical signal 182 may include, for example, a light emitted and / or reflected from the sensor material 176, wherein emitted light may be emitted, for example, in the form of fluorescent light and / or luminescent light.
  • This optical signal 182 of the sensor material 176 is preferably sensitive to the presence of an analyte in the body tissue 116 surrounding the sensor end 168.
  • a reference material 184 can also be contained in the sensor region 172, which can also contribute to the optical signal 182 and can reflect or emit a reference component of this optical signal 182.
  • FIG. 1 illustrated that the transparent coupling part 174 serves as a "window" for the extraction of an optical signal 182.
  • This optical signal 182 may include, for example, a light emitted and / or reflected from the sensor material 176, wherein emitted light may be emitted, for example, in the form of fluorescent light
  • an optional excitation beam 186 is shown, by means of which, for example, the sensor material 176 and / or the reference material 184 can be specifically excited.
  • the requirement of using such excitation beam 186 is dependent upon the type of sensor material 176 and / or reference material 184 and / or the optical detection mechanism used to detect the at least one analyte in body tissue 116 and / or body fluid surrounding sensor region 172 ,
  • the coupling part 174 can serve as an optical waveguide, but can also be configured as a simple, homogeneous and transparent window without optical waveguide properties.
  • the coupling part 174 then acts only as a window for viewing the sensor area 172 from the outside area 188 outside the skin surface 112.
  • the sensor element 114 is preferably implanted in the body tissue 116 such that its coupling end 170 is still disposed below the skin surface 112.
  • the skin surface 112 above the coupling end 170 is preferably already healed again in measuring mode.
  • a body tissue 116 As an example of a body tissue 116 is shown in the in FIG. 2 illustrated embodiment, a skin portion with an epidermis 190, a dermis 192 and a subcutis 194 shown, wherein a hair 196 is shown as an example of a size comparison. Symbolic are in FIG. 2 furthermore, the absorption ⁇ and the scattering ⁇ are plotted. It can be seen that the scattering ⁇ and the absorption ⁇ in the area of the skin surface 112 are low and increase with increasing depth in the interior of the body tissue 116. It should be noted that the skin portion shown is merely an example of a location of the implantation, so that implantation can also take place in other types of body tissue 116, such as a tissue within an eye or in other types of body tissue.
  • the detection device 164 includes, if optical detection methods and optical sensor element 114 are used, the detection device 164, for example, at least one optical detector 198. If other types of sensor elements 114 are used, correspondingly different types of detection devices may be provided, for example electrical detection devices, for example for detecting a charge, a voltage or a current.
  • the optical detector 198 is in FIG. 2 only symbolically represented and symbolized here as a photodiode. However, a variety of optical detectors and / or additional devices, for example, devices for spectral separation of the optical signal 182, may be provided to specifically detect the optical signal 182 of the sensor material 176 and / or the reference material 184, and optionally spectrally resolved.
  • the detection device 164 is in FIG. 2 is configured such that it can be coupled to the coupling end 170 of the sensor element 114, wherein the coupling preferably through the uppermost layers of the body tissue 116 therethrough can be done. For example, the detection device 164 can be placed on the skin surface 112 for this purpose.
  • the detection device 164 is in FIG. 2
  • Optionally equipped with additional optical devices 200 which are also shown symbolically symbolic and which may include, for example, corresponding optics such as lenses, lenses, diaphragms or the like.
  • the detection device 164 in the in FIG. 2 illustrated embodiment optionally at least one radiation source 202 for generating the optional excitation beam 186.
  • the radiation source 202 is in turn shown symbolically as a light emitting diode, but a variety of other types of radiation sources may be included.
  • the detection device 164 may further include additional components, such as input and output means, power supplies, data processing equipment, or the like.
  • additional components such as input and output means, power supplies, data processing equipment, or the like.
  • the signal generated by the implanted sensor 114 can be processed and, for example, converted into an analyte concentration.
  • An immediate display of this analyte concentration to a user is optionally possible, for example.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Element Separation (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Optical Integrated Circuits (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Claims (14)

  1. Dispositif d'implantation (110) pour l'implantation d'un élément de capteur (114) pour détecter au moins un analyte dans un liquide corporel ou un tissu corporel (116), comprenant au moins une canule (118) destinée à pénétrer à travers la surface de la peau (112) d'un patient, la canule (118) présentant au moins une région de réception (124) pour recevoir l'élément de capteur (114), le dispositif d'implantation (110) présentant en outre au moins un récipient hydraulique (128) connecté à la canule (118) pour recevoir un fluide hydraulique (132), le dispositif d'implantation (110) présentant en outre au moins un dispositif de génération de pression (142), le dispositif de génération de pression (142) étant prévu pour solliciter le fluide hydraulique (132) avec une pression, l'élément de capteur (114) pouvant être transféré au moyen du fluide hydraulique (132) hors de la canule (118) dans le tissu corporel (116), le récipient hydraulique (128) étant connecté par le biais d'au moins une connexion (136) à une réserve hydraulique (138) pour recevoir et fournir le fluide hydraulique (132), la connexion (136) comprenant au moins une soupape (140), notamment un clapet anti-retour.
  2. Dispositif d'implantation (110) selon la revendication précédente, comprenant en outre au moins un dispositif (154) pour ajuster et/ou limiter la profondeur d'implantation, notamment une butée de profondeur (156).
  3. Dispositif d'implantation (110) selon la revendication précédente, dans lequel le dispositif (154) pour ajuster et/ou limiter la profondeur d'implantation comprend une surface d'appui (150) à appuyer contre la surface de la peau (112), notamment une surface d'appui (150) entourant au moins en partie de manière annulaire la canule (118).
  4. Dispositif d'implantation (110) selon l'une quelconque des deux revendications précédentes, dans lequel la canule (118) et le récipient hydraulique (128) forment une unité d'implantation (130), le dispositif (154) pour ajuster et/ou limiter la profondeur d'implantation étant connecté à l'unité d'implantation (130) par le biais d'au moins un élément à ressort (160).
  5. Dispositif d'implantation (110) selon l'une quelconque des revendications précédentes, dans lequel la soupape (140) est prévue pour s'ouvrir dans le cas d'une dépression dans le récipient hydraulique (128) et pour permettre un reflux de fluide hydraulique (132) dans le récipient hydraulique (128).
  6. Dispositif d'implantation (110) selon l'une quelconque des revendications précédentes, dans lequel le dispositif de génération de pression (142) comprend au moins un piston de pression (144), notamment un piston de pression (144) reçu dans le récipient hydraulique (128).
  7. Dispositif d'implantation (110) selon la revendication précédente, dans lequel la canule (118) et le récipient hydraulique (128) forment une unité d'implantation (130), l'unité d'implantation (130) pouvant être déplacée par rapport au piston de pression (144) axialement le long d'un axe (134) du dispositif d'implantation (110).
  8. Dispositif d'implantation (110) selon l'une quelconque des deux revendications précédentes, dans lequel une position du piston de pression (144) par rapport à la surface de la peau (112) peut être fixée, le piston de pression (144) étant connecté à au moins une surface d'appui (150), notamment la surface d'appui (150) du dispositif (154) pour ajuster et/ou limiter la profondeur d'implantation, la connexion étant réalisée notamment par une tringle de piston (146).
  9. Dispositif d'implantation (110) selon l'une quelconque des revendications précédentes, dans lequel le fluide hydraulique (132) comprend une solution saline, notamment une solution de sel physiologique.
  10. Dispositif d'implantation (110) selon l'une quelconque des revendications précédentes, dans lequel la canule (118) est au moins partiellement transparente à la lumière, en particulier la lumière dans la plage spectrale ultraviolette.
  11. Dispositif d'implantation (110) selon la revendication précédente, comprenant en outre au moins une source de lumière pour réticuler au moins un matériau réticulable de l'élément de capteur (114) dans la canule (118).
  12. Dispositif d'implantation (110) selon l'une quelconque des revendications précédentes, dans lequel la canule (118) présente au moins un rétrécissement (126) pour limiter la région de réception (124).
  13. Dispositif d'implantation (110) selon l'une quelconque des revendications précédentes, dans lequel le dispositif d'implantation (110) est en outre prévu pour enlever un élément de capteur (114) implanté dans le tissu corporel (116), le dispositif de génération de pression (142) étant prévu pour produire une dépression dans le fluide hydraulique (132), l'élément de capteur (114) pouvant être aspiré dans la canule (118).
  14. Dispositif d'implantation (110) selon l'une quelconque des revendications précédentes, comprenant en outre au moins un élément de capteur (114) pour détecter au moins un analyte dans un liquide corporel ou un tissu corporel (116).
EP08165704A 2008-10-02 2008-10-02 Dispositif d'implantation pour capteurs de métabolites Active EP2174587B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE502008003439T DE502008003439D1 (de) 2008-10-02 2008-10-02 Implantationsvorrichtung für Metabolitsensoren
EP08165704A EP2174587B1 (fr) 2008-10-02 2008-10-02 Dispositif d'implantation pour capteurs de métabolites
AT08165704T ATE507768T1 (de) 2008-10-02 2008-10-02 Implantationsvorrichtung für metabolitsensoren
ES08165704T ES2364375T3 (es) 2008-10-02 2008-10-02 Dispositivo de implantación para sensores de metabolitos.
TW98132727A TWI471116B (zh) 2008-10-02 2009-09-28 用於代謝產物感測器的植入裝置
US13/122,110 US8652101B2 (en) 2008-10-02 2009-10-02 Implantation device for metabolite sensors
CN200980144403.0A CN102209489B (zh) 2008-10-02 2009-10-02 代谢产物传感器的植入装置
CA2739236A CA2739236C (fr) 2008-10-02 2009-10-02 Dispositif d'implantation pour detecteurs de metabolites
PCT/EP2009/062824 WO2010037848A1 (fr) 2008-10-02 2009-10-02 Dispositif d'implantation pour détecteurs de métabolites
HK12102304.3A HK1161965A1 (en) 2008-10-02 2012-03-07 Implantation device for metabolite sensors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08165704A EP2174587B1 (fr) 2008-10-02 2008-10-02 Dispositif d'implantation pour capteurs de métabolites

Publications (2)

Publication Number Publication Date
EP2174587A1 EP2174587A1 (fr) 2010-04-14
EP2174587B1 true EP2174587B1 (fr) 2011-05-04

Family

ID=40220205

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08165704A Active EP2174587B1 (fr) 2008-10-02 2008-10-02 Dispositif d'implantation pour capteurs de métabolites

Country Status (10)

Country Link
US (1) US8652101B2 (fr)
EP (1) EP2174587B1 (fr)
CN (1) CN102209489B (fr)
AT (1) ATE507768T1 (fr)
CA (1) CA2739236C (fr)
DE (1) DE502008003439D1 (fr)
ES (1) ES2364375T3 (fr)
HK (1) HK1161965A1 (fr)
TW (1) TWI471116B (fr)
WO (1) WO2010037848A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9517023B2 (en) 2009-06-01 2016-12-13 Profusa, Inc. Method and system for directing a localized biological response to an implant
US10463287B2 (en) 2010-10-06 2019-11-05 Profusa, Inc. Tissue-integrating sensors
US10010272B2 (en) 2010-05-27 2018-07-03 Profusa, Inc. Tissue-integrating electronic apparatus
US20130253332A1 (en) * 2012-03-20 2013-09-26 Nellcor Puritan Bennett Llc Tissue interface systems for application of optical signals into tissue of a patient
AU2014241420B2 (en) 2013-03-14 2018-05-31 Profusa, Inc. Method and device for correcting optical signals
CA2913474C (fr) 2013-06-06 2023-04-18 William A. Mcmillan Appareil et procedes pour detecter des signaux optiques a partir de capteurs implantes
EP3367913B1 (fr) * 2015-09-11 2020-09-02 Pop Test LLC Dispositif thérapeutique
US11331018B2 (en) 2016-12-22 2022-05-17 Profusa, Inc. System and single-channel biosensor for and method of determining analyte value
CN116421145A (zh) * 2020-05-30 2023-07-14 深圳硅基传感科技有限公司 自动化的批量植入装置

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9101197A (nl) * 1991-07-08 1993-02-01 Texas Instruments Holland Injector.
US5288291A (en) * 1992-08-12 1994-02-22 Datapet, Inc. Method and apparatus for simultaneously injecting a liquid and a transponder into an animal
WO1994004207A1 (fr) * 1992-08-17 1994-03-03 Allard Edward F Procede et dispositif pour aiguille retractable
JP2000014662A (ja) * 1998-01-22 2000-01-18 Terumo Corp 体液検査装置
US6496561B1 (en) * 1998-03-06 2002-12-17 Medtronic Ave, Inc. Devices, methods and systems for delivery of X-ray
HU226183B1 (en) 1999-08-26 2008-06-30 Novartis Ag Ophthalmic lens and sensor system for measuring the concentration of an analyte in an ocular fluid
ES2295344T3 (es) 2001-04-27 2008-04-16 Eyesense Ag Kit para medir concentraciones de glucosa en sangre.
US7226414B2 (en) 2002-10-09 2007-06-05 Biotex, Inc. Method and apparatus for analyte sensing
CN100473339C (zh) * 2002-12-13 2009-04-01 爱科来株式会社 穿刺装置
US8216854B2 (en) 2003-01-07 2012-07-10 Biotex, Inc. Device and method for measuring analytes
EP1527792A1 (fr) * 2003-10-27 2005-05-04 Novo Nordisk A/S Dispositif d'injection médicale montable sur la peau
US7496392B2 (en) 2003-11-26 2009-02-24 Becton, Dickinson And Company Fiber optic device for sensing analytes
US20070173706A1 (en) * 2005-11-11 2007-07-26 Isense Corporation Method and apparatus for insertion of a sensor
US20080139903A1 (en) * 2006-12-08 2008-06-12 Isense Corporation Method and apparatus for insertion of a sensor using an introducer

Also Published As

Publication number Publication date
DE502008003439D1 (de) 2011-06-16
ES2364375T3 (es) 2011-09-01
ATE507768T1 (de) 2011-05-15
TWI471116B (zh) 2015-02-01
CA2739236C (fr) 2014-05-13
EP2174587A1 (fr) 2010-04-14
US20110230835A1 (en) 2011-09-22
WO2010037848A1 (fr) 2010-04-08
HK1161965A1 (en) 2012-08-17
CN102209489A (zh) 2011-10-05
US8652101B2 (en) 2014-02-18
CN102209489B (zh) 2014-01-15
TW201023821A (en) 2010-07-01
CA2739236A1 (fr) 2010-04-08

Similar Documents

Publication Publication Date Title
EP2174587B1 (fr) Dispositif d'implantation pour capteurs de métabolites
EP2174586B1 (fr) Elément de capteur implantable
EP2139396B1 (fr) Appareil de perçage et appareil d'analyse
EP1420694B1 (fr) Systeme de prelevement de liquides organiques en petites quantites
DE10325699B3 (de) System zur Analyse einer zu untersuchenden Probe und Verwendung eines solchen Systems
DE19781097B4 (de) Blut- und Körperfluidprobenentnahmevorrichtung sowie Verfahren zur Erlangung einer Körperfluidprobe
EP3074082B1 (fr) Auxiliaire de placement d'un cathéter pour diabétique
EP2129289B1 (fr) Système d'analyse pour la détermination d'un analyte dans un liquide corporel, et élément de prélèvement d'échantillon et d'analyse intégré jetable
DE102005007901A1 (de) Katheter mit Mikrokanälen für die Überwachung der Konzentration eines Analyten in einer Körperflüssigkeit
DE102005042849A1 (de) Implantationswerkzeug für Intraokularlinsen
EP1882492A1 (fr) Dispositif pour une pénétration controlée dans un objet et procédé pour faire fonctionner ce dispositif
DE60215645T2 (de) Vorrichtungen zum ausdrücken von körperflüssigkeiten aus einem einschnitt
EP2786121B1 (fr) Chambre de mesure pour un capteur optique de détermination de la concentration d'une substance dans le liquide tissulaire d'un mammifère
EP0708669A1 (fr) Procede permettant d'acceder a une veine et dispositif de mise en oeuvre dudit procede
WO2010037816A1 (fr) Dispositif et procédé pour le diagnostic et le pronostic précoces de processus cicatriciels, en particulier en présence de lésions osseuses
EP2059169B1 (fr) Dispositif médical
DE202013101907U1 (de) Frontelement für eine optische Messsonde und Messsondenvorrichtung
WO2007057095A1 (fr) Appareil de detection de valeurs de diagnostic dans le corps

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090429

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REF Corresponds to:

Ref document number: 502008003439

Country of ref document: DE

Date of ref document: 20110616

Kind code of ref document: P

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502008003439

Country of ref document: DE

Effective date: 20110616

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: SCHMAUDER & PARTNER AG PATENT- UND MARKENANWAELTE

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20110504

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2364375

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20110901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110804

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110905

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110904

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110805

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20120207

BERE Be: lapsed

Owner name: EYESENSE A.G.

Effective date: 20111031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111031

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502008003439

Country of ref document: DE

Effective date: 20120207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111002

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110804

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110504

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 507768

Country of ref document: AT

Kind code of ref document: T

Effective date: 20131002

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20131002

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231025

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20231117

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20231031

Year of fee payment: 16

Ref country code: FR

Payment date: 20231023

Year of fee payment: 16

Ref country code: DE

Payment date: 20231018

Year of fee payment: 16